WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 2, 2006--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the design, development and sale of proprietary products used to diagnose neuropathies, or diseases of the nerves, announced today the financial results for the three month and twelve month periods ended December 31, 2005.
